PPP1R9B

Across TCGA pan-cancer cohorts, PPP1R9B mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated PPP1R9B data layer compared with 25 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher PPP1R9B mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated PPP1R9B expression acts as an unfavorable survival marker, although some lineages such as LUAD and CCRCC show a favorable association.

LUAD, LSCC, and GBM are the cancer types where PPP1R9B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.960	0.875	.002	15	view →
LSCC	DFS	Quartile	II,III,IV	0.559	0.945	.013	12	view →
GBM	OS	Median	All	0.376	0.626	.035	3	view →
CCRCC	OS	Quartile	III,IV	0.905	0.563	.032	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

PPP1R9B–LUAD (DFS)

Open the LUAD breakdown →